🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Williams Syndrome (WS) is a rare neurodevelopmental disorder, usually cause...
Status
Not Yet Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-04-01
Trial ID
NCT07509879
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
Hepatocellular carcinoma is an aggressive disease with limited therapeutic ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-11
Trial ID
NCT00911196
Treatments Being Tested
This research study is looking at tissue samples from women with breast can...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT00898898
Treatments Being Tested
Primary objective of the study is to evaluate the correlation between level...
Status
Unknown
Location
Istituto Clinco Humanitas
Start Date
2009-03
Trial ID
NCT00874146
Treatments Being Tested
RATIONALE: Azadirachta indica may be an effective treatment for chronic lym...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251250
Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnosti...
Status
Recruiting
Location
CHU de Montpellier
Start Date
2024-11-19
Trial ID
NCT06523543
RATIONALE: Drugs used in chemotherapy, such as fludarabine phosphate, work ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00845104
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tiss...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-09
Trial ID
NCT00049010